跳至主要内容
临床试验/IRCT20190127042516N1
IRCT20190127042516N1招募中未知

The effect of discontinuation of angiotensin-II receptor blocker on therapeutic effect of synthetic erythropoietin on anemia modification in hemodialysis patients

Islamic Azad University0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • All hypertensive patients with ESRD on regular hemodialysis consist of 3 4-hours session per week.
  • Use of Losartan at least the last three months

排除标准

  • Dosage alteration for rHuEPO, ferrous sulfate and Carnitine supplementation.
  • Serious infection leading hospitalization
  • Obvious bleeding
  • Transfusion
  • CRP>10 mg/L
  • Serum Ferritin <100 ng/ml
  • Any alteration in hemodialysis dosage/time

研究者

相似试验